Pharma-funded studies far more likely to find oncology drugs cost-effective

Studies funded by pharmaceutical companies appeared significantly more likely to find oncology drugs cost-effective than studies without such funding, according to results of a cross-sectional study published in JAMA Network Open . “To weigh the costs and benefits of a drug , researchers and organizations will conduct a cost-effectiveness analysis.

Read the source article at Healio
2022-02-04 17:20:40